research chemical is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-05-03. Where a claim depends on a specific study, the study is described rather than over-claimed.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
| Property | Value | Notes |
|---|---|---|
| Molar mass | Approximately 1419.5 g/mol | Calculated from the reported 15-residue sequence |
| Molecular formula | C62H98N16O22 | Based on the same sequence |
| Appearance | White to off-white powder | Typical of a lyophilized preparation |
| Solubility class | Freely soluble in water | Also dissolves in saline solutions |
| Typical storage temperature | Minus 20 degrees Celsius, dry | Refrigeration advised after reconstitution |
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
=== Lactose fermentation === In one study that sought to prove that some fermentation produced by L. lactis can hinder motility in pathogenic bacteria, the motilities of Pseudomonas, Vibrio, and Leptospira strains were severely disrupted by lactose utilization on the part of L. lactis. Using flagellar Salmonella as the experimental group, the research team found that a product of lactose fermentation is the cause of motility impairment in Salmonella. It is suggested that the L. lactis supernatant mainly affects Salmonella motility through disruption of flagellar rotation rather than through irreversible damage to morphology and physiology. Lactose fermentation by L. lactis produces acetate that reduces the intracellular pH of Salmonella, which in turn slows the rotation of their flagella. These results highlight the potential use of L. lactis for preventing infections by multiple bacterial species.
== Function in medicine == Arenobufagin has been widely used in traditional Chinese medicine (TCM) to attempt to treat carcinogenesis, since it inhibits cell growth in several cancer cells. It is one of the central active ingredients of toad toxin for this treatment. This happens both in purified form or in combination with other ingredients, which are mostly herbal components. Toad toxin is in fact still used in clinical practice in TCM to treat hepatocellular carcinoma (HCC). So far there is still little known about the anti-angiogenic properties of Arenobufagin. One study shows that Arenobufagin inhibits VEGF-induced endothial cell tube formation.
=== Amine hormones === Hormones derived from the modification of amino acids are referred to as amine hormones. Typically, the original structure of the amino acid is modified such that a –COOH, or carboxyl, group is removed, whereas the –NH+3, or amine, group remains. Amine hormones are synthesized from the amino acids tryptophan or tyrosine.
Sources: en.wikipedia.org
== Uses == Warm compresses are a common non-pharmacological therapy used in the treatment of things such as sports injuries, dental pain, post-operative wound healing, and ophthalmic conditions. They are believed to improve blood flow, increase oxygenation in tissues and help manage inflammation.
He also appeared on special episodes, like Raw's 25th anniversary episode, Raw Reunion, In 2022, Austin had his first feud since his retirement with Kevin Owens. At WrestleMania 38, Austin defeated Owens in a No Holds Barred match, his first match in 19 years.
Art to be viewed from space – The Nazca Lines were created by the ancient Nazca culture in modern-day Peru. The Nazca built these artworks, which could only be viewed from the sky or from space. It was as if the Nazca were building monuments, which only their gods could view from up in the sky. Some of these artworks, otherwise known as the Nazca Lines, could only be viewed from the sky and each one of these works of Nazca art spans several miles across in size and dimension in the Sechura Desert. Aqueducts – The ancient Andean cultures, such as Chimu, Moche and Nazca, lived in dry environments, yet they sustained large scale agriculture consisting of a wide variety of crops by employing aqueducts connecting various freshwater sources, such as mountain streams and lakes to their agricultural fields which were sometimes injecting pressure with the aid of puquios (wind-based water pumps). The Inca later expanded on these previously constructed aqueducts and built a more complex and large aqueduct system in the Inca Empire. The Mesoamerican Aztecs also constructed complex, dual-pipe aqueducts to supply their vast city of Tenochtitlan. Aspirin – Indigenous Americans have been using willow tree bark for thousands of years to reduce fever and pain as were the peoples of Assyria, Sumer, Ancient Egypt and Ancient Greece. When chemists analyzed willows in the last century, they discovered salicylic acid; the basis of the modern drug aspirin.
Sources: en.wikipedia.org
Marcos Nogueira Eberlin (born 4 March 1959) is a Brazilian chemist and former professor at the Institute of Chemistry of the University of Campinas. He is a member of the Brazilian Academy of Sciences and received the Brazilian National Order of Scientific Merit in 2005 and the Thomson Medal in 2016. Eberlin discovered the Eberlin reaction during his work on gas-phase ion chemistry. He and his research group introduced EASI (Easy Ambient Sonic-spray Ionization), an ionization technique used in mass spectrometry. Eberlin is an advocate of intelligent design in Brazil, on which he also lectures and he has signed the Dissent From Darwinism statement. He is a creationist also, and has said that evolution theory is a fallacy. His daughter, Livia S. Eberlin, is also a chemist who won the MacArthur "Genius" Fellowship in 2018 for her research on the use of mass spectrometry to diagnose cancer. Eberlin and his daughter have worked together on a different project, using mass spectrometry to detect counterfeit money.
GoldSrc (pronounced "gold source", formerly the Half-Life Engine) is a proprietary game engine developed by Valve. At its core, GoldSrc is a heavily modified version of id Software's Quake engine. It made its debut in 1998 with Half-Life and powered future games developed by or with oversight from Valve, including Half-Life's expansions, Day of Defeat and games in the Counter-Strike series. GoldSrc was succeeded by the Source engine with the releases of Half-Life: Source, Half-Life 2, and Counter-Strike: Source in 2004.
The amylin receptors (AMYRs) are a family of 3 receptors that are activated by amylin, a peptide hormone secreted together with insulin. They are each composed of a copy of the calcitonin receptor (CTR) bound to a receptor activity-modifying protein (RAMP), forming a heterodimer. They consist of AMY1 (RAMP1 with CTR), AMY2 (RAMP2 with CTR), and AMY3 (RAMP3 with CTR). Activation of these receptors appears to have a number of effects on eating behavior, including triggering feelings of satiation, reducing food intake, decreasing fat storage, and increasing energy usage. These effects have led to research into targeting these receptors with treatments for metabolic diseases and obesity. The amylin receptors are G protein-coupled receptor of the secretin receptor family. Consistent with their calcitonin receptor subunit, they appear to activate Gs alpha subunit pathways, and there have also been reports of Gq alpha subunit coupling. However, methodological difficulties related to amylin’s ability to bind with the calcitonin receptor have led some researchers to express uncertainty about these results.
Sources: en.wikipedia.org
It does not occur in the form that is supplied commercially. Its sequence matches a fragment of a larger gastric protein, and the research material is produced synthetically in a laboratory. The fragment described in the early literature is generally the same synthetic pentadecapeptide.
It marks the position of the sequence inside the original protein. The label traces back to early work fractionating gastric juice and describing a body protection compound. The figure does not refer to molecular weight or to the count of amino acids.
No. The sequence has no cysteine residues, so disulfide bridges cannot form. That feature makes it easier to handle than many small proteins that depend on multiple cysteines for structure.
It is a synthetic peptide built from fifteen amino acids, with a mass of roughly 1419 daltons. The sequence is reported to match a fragment of a protein present in human gastric juice. It is not a naturally circulating hormone.